Benign Prostatic Hyperplasia (BPH) Therapeutics Market -
Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019
Benign prostatic hyperplasia (BPH) or benign prostatic
hypertrophy, is a urological disorder that involves proliferation of the
cellular components of the prostrate. BPH is the most common form of neoplasm
in men. BPH results in the formation of large nodes and nodules in the
periurethral region of the prostate. The significantly large nodules compresses
the urethral canal that causes to partial or complete urinary tract obstruction
which inhibits the normal flow of urine. Obstruction in the urinary tract
further leads to complications such as urinary retention, urinary tract
infections and urinary hesitancy.
Browse Full Report With TOC:
Some of the medical therapies used for the treatment of BPH
are as follows:
• Alpha-Blockers
• 5-
Alpha-reductase inhibitors (5-ARIs)
• Alpha-Adrenergic
Blockers
• Phosphodiesterase-5
Enzyme Inhibitors
• Anticholinergic
Agents
• Nonselective
alpha-blockers
Some of the surgical interventions used of the treatment of
BPH are as follows:
• Holmium
Laser Resection of the Prostate (HoLRP)
• Open
prostatectomy
• Photoselective
vaporization of the prostate (PVP)
• Transurethral
holmium laser ablation of the prostate (HoLAP)
• Transurethral
resection of the prostate (TURP)
• Transurethral
vaporization of the prostate (TUVP)
• Transurethral
incision of the prostate (TUIP)
Geographically, North America is the leading market due to
high prevalence rate of benign prostatic hyperplasia and lower urinary tract
symptoms (LUTS). Various studies reports that 90% of men in the U.S., aged
between 45 and 80 years suffer from some type of LUTS and approximately 14
million men in the U.S. have symptoms of BPH. Asia-Pacific is also expected to
witness a significant growth due to the rise in various urological disorders
and complications. However, BPH tends to be more progressive in
African-American men owing to the presence of high testosterone level in their
body.
Download Full Report with TOC:
Rise in geriatric population is expected to be one of the major
driver that might drive the market. Additionally, increased awareness for
prostate cancer and other urological disorders, are also expected to fuel the
growth of the global BPH therapeutics market. However, high adoption rate of
minimally invasive surgeries such as transurethral microwave thermotherapy
(TUMT), laparoscopic prostatectomy and transurethral needle ablation (TUNA)
might impede the growth of the BPH therapeutics market.
Some of the key players in the benign prostatic hyperplasia
(BPH) therapeutics Market are AEternaZentaris Inc., Astellas Pharma Inc., Eli
Lilly and Company, EndoCeutics, Inc., IntelGenx Technologies Corp., Ipsen S.A.,
Nymox Pharmaceutical Corporation, Protox Therapeutics Inc. and Quest PharmaTech
Inc.
This research report analyzes this market depending on its
market segments, major geographies, and current market trends. Geographies
analyzed under this research report include
• North
America
• Asia
Pacific
• Europe
• Rest of
the World
This report provides comprehensive analysis of
• Market
growth drivers
• Factors
limiting market growth
• Current
market trends
• Market
structure
• Market
projections for upcoming years
This report is a complete study of current trends in the
market, industry growth drivers, and restraints. It provides market projections
for the coming years. It includes analysis of recent developments in
technology, Porter’s five force model analysis and detailed profiles of top
industry players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with detailed
value chain analysis.
Visit Complete Report:
Reasons for Buying this Report
• This
report provides pin-point analysis for changing competitive dynamics
• It
provides a forward looking perspective on different factors driving or
restraining market growth
• It
provides a technological growth map over time to understand the industry growth
rate
• It
provides a seven-year forecast assessed on the basis of how the market is
predicted to grow
• It helps
in understanding the key product segments and their future
• It
provides pin point analysis of changing competition dynamics and keeps you
ahead of competitors
• It helps
in making informed business decisions by having complete insights of market and
by making in-depth analysis of market segments
• It
provides distinctive graphics and exemplified SWOT analysis of major market
segments
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
